pentobarbital sodium contraindications for Dummies
pentobarbital sodium contraindications for Dummies
Blog Article
pentobarbital will decrease the level or effect of brexpiprazole by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Watch Carefully. Double brexpiprazole dose over one-2 months if administered with a strong CYP3A4 inducer.
pentobarbital will lower the extent or effect of ibuprofen by impacting hepatic enzyme CYP2C9/10 metabolism. Minor/Significance Unknown.
pentobarbital will decrease the extent or effect of triazolam by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Check.
benzhydrocodone/acetaminophen and pentobarbital each increase sedation. Stay clear of or Use Alternate Drug. Restrict use to sufferers for whom alternative cure possibilities are insufficient
pentobarbital will lower the extent or effect of propafenone by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Minimal/Significance Not known.
pentobarbital will minimize the extent or effect of roflumilast by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Coadministration not suggested; potent cytochrome P450 enzyme inducers lessen systemic publicity to roflumilast and will lessen the therapeutic effectiveness
pentobarbital will minimize the extent or effect of alosetron by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Small/Significance Unfamiliar.
fentanyl transdermal and pentobarbital both improve sedation. Avoid or Use Alternate Drug. Limit get more info use to sufferers for whom alternative remedy solutions are inadequate
pentobarbital will decrease the extent or effect of disopyramide by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Slight/Significance Unknown.
fentanyl intranasal and pentobarbital both equally improve sedation. Avoid or Use Alternate Drug. Restrict use to individuals for whom alternative therapy choices are insufficient
pentobarbital will lower the extent or effect of lapatinib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.
pentobarbital will reduce the extent or effect of tipranavir by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Check.
pentobarbital will lower the level or effect of cevimeline by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Minimal/Significance Mysterious.
pentobarbital decreases levels of panobinostat by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Powerful CYP3A4 inducers can minimize panobinostat ranges by ~70% and result in therapy failure.